Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.
The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand said on Sunday that he had received "guarantees".
France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...
Some results have been hidden because they may be inaccessible to you